Pfizer, Astellas Prostate Cancer Drug Promising in Late-Stage Trial

Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.

Read more.

Source: Reuters

ZERO+1 Caregiver - Web Banner

ZERO+One Caregiver Retreat

November 15 –16, 2025 | Atlanta, Georgia

ZERO believes every prostate cancer patient and survivor should have a “plus one” - a caregiver - in their corner. If you’ve been serving as a “plus one,” whether you're a partner, spouse, son, daughter, sibling, or friend, join us for an in-person gathering designed specifically for you – the caregivers and care partners who often put the needs of others before your own.

Reserve Your Spot
Share